Back to Awarded Treatment Trials


Awarded Trial: 01T-432

Grant ID

01T-432

Illness

Schizophrenia

Primary Drug/Intervention

Riluzole

Primary Dosage

50mg

Secondary Drug Intervention

N/A

Secondary Dosage

N/A

Other Drug/Intervention

N/A

Other Dosage

N/A

Status

Completed

Investigator

Zimolo

Sample Size

30

Duration of Study Period for Each Subject

12 weeks

Outcome Measurements

PANSS, CGI, Cognitive Battery

Results

Twenty patients completed the study. There were no significant differences between drug and placebo.

Publication

N/A

Link

N/A

PI Name

Zoran Zimolo

Degree

MD

Center

Department of Psychiatry

Institution

Yale University School of Medicine

Address

950 Campbell Ave

City or Town

New Haven

State or Province

CT

Zip or Postal Code

6516

Country

USA

Email Address

zoran.zimolo@yale.edu